Sustainability Report

The report highlights BD's COVID-19 response, including a rapid point-of-care antigen test and expanded diagnostic capabilities. It reports a 58% normalized reduction in combined Scope 1 and 2 emissions from the FY 2008 baseline and sets a 46% reduction target by 2030, alongside a commitment to carbon neutrality across direct operations by 2040. It also describes FY 2020 initiatives to expand healthcare access, improve environmental performance and support its global workforce.